Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Paraesthesia
Clinical narrative: Iron and transferrin are low; Iron and transferrin are low; folic acid low; B12 level was low; hemoglobin was very low; CT Scan: No acute intracranial pathology seen, small right parietal calcified meningioma/MRI: Small benign meningioma in right parietal lobe; facial paralysis; This is a spontaneous report from a contactable consumer (Patient). A 39-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: E126205) via an unspecified route of administration, administered in arm left on 09Mar2021 (at the age of 39 years) as dose 2, single for COVID-19 immunization at school. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: E19264) via an unspecified route of administration in left arm on 16Feb2021 (at the age of 39 years) for COVID-19 immunization. Consumer reported that on 05Apr2021, consumer has facial paralysis after the administration of the second dose of the Pfizer Covid-19 vaccine. Consumer reported that consumer has gone to the physician and is under treatment right now. Consumer went to the emergency room for the paralysis. Consumer reported that consumer was still suffering from the facial paralysis. Consumer reported that the only thing that was slightly better was that the facial paralysis was on the right side and her right eye wouldn't close and was open 100 percent. Consumer reported that her right eye does close now, but remains slightly open. Consumer reported that consumer has to really work to close her eye, but consumer was able to close it. On 24Jun2021, consumer had to see the ophthalmologist due to pain in her eye related to lacerations from her eye being open all the time. Consumer reported that the doctor suggested that consumer have surgery to close her right eye so that it can be protected while she recuperates from the paralysis. Consumer reported that consumer began receiving B-12 injections and taking another medication called Theraplex that has folic acid after her facial paralysis began to help with the recuperation process. Consumer reported that for the month of Apr2021 and May2021, her physician would inject the B-12 once a month. Consumer reported that starting 2 weeks ago, she started injecting herself with 0.5 CC of B-12 twice per week. Consumer reported that she had tests done and her B12 level was low and her hemoglobin was very low which is why she takes Theraplex and Folic acid. Consumer reported that after the Covid-19 vaccine consumer has gotten a whole bunch of things. Consumer reported that consumer went to the emergency room and they were the ones that did the CT scan in early morning on 05Apr2021, No acute intracranial pathology seen, small right parietal calcified meningioma, had an MRI on 22Apr2021, Small benign meningioma in right parietal lobe, no other significant intracranial pathology. Consumer reported that her physician informed her that transferrin is a reserve for iron in the body; Chemistry with B-12 and Folic acid on 08Apr2021: Folic acid and B-12 low, Hemoglobin test on 05Apr2021: Hemoglobin low, Unspecified lab work on 04May2021: Iron and transferrin are low. Consumer reported that her appointment was for 10:30, but they were running behind. Consumer reported that consumer thought she received the second dose of the Covid-19 vaccine at 12:05, but consumer knew it was before 13:00. Consumer reported that she answered previously that she went to the emergency room on 05Apr2021 and has been seeing other doctors since. Consumer stated that apart from reporting this, she just wanted to also report that she has not gotten better, that she continues to be received treatment. The outcome of events facial paralysis was not recovered and for the rest events was unknown.